NCT04203316 · Interventional trial
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation
Overall registry status Active not recruiting
Phase 2
Conditions Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory